Willebrand International Non-interventional Global Surveillance
NCT ID: NCT01949220
Last Updated: 2018-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2014-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bleeding Incidence in VWD Patients Undergoing On-Demand Treatment
NCT04053699
Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)
NCT01410227
Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age
NCT04953884
Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of Bleeding
NCT02792205
Real-life Data of Constitutional Von Willebrand Disease in Western France
NCT04887324
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Von Willebrand factor deficient patient
Inherited von Willebrand disease
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients treated with WILLFACT or WILFACTIN
* Patient or parent/legal representative who has provided written signed and dated informed consent before any data collection.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoire français de Fractionnement et de Biotechnologies
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfgang MIESBACH, Dr
Role: STUDY_DIRECTOR
Medizinische Klinik III, Goethe Universitat, D-60590 Frankfurt/Main (Germany)
Flora PEYVANDI, Prof.
Role: STUDY_DIRECTOR
Faculty of Medicine, University of Milan, 20122 Milan (Italy)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital des enfants Reine Fabiola
Antwerp, , Belgium
UZA hopital universitaire
Edegem, , Belgium
University Hospital
Brno, , Czechia
University Central Hospital
Helsinki, , Finland
Charité Universitätsmedizin
Berlin, , Germany
GZRR Gerinnungszentrum Rhein/ Ruhr
Duisburg, , Germany
Universitatsklinikum
Essen, , Germany
Goethe Universitat
Frankfurt, , Germany
Medizinische Hochschule Hannover
Hanover, , Germany
Werlhof-Institut für Hämostaseologie GmbH
Hanover, , Germany
Universitätsklinikum Schleswig-Holstein
Kiel, , Germany
Universitatsklinikum
Mainz, , Germany
Klinikum der Universität
München, , Germany
Hemophilia center "LAIKO" general hospital
Athens, , Greece
Centro di Riferimento Regionale per Emofilia e Trombosi
Catania, , Italy
AOUC- Azienda Ospedaliero-Universitaria Carregi
Florence, , Italy
University of Milan
Milan, , Italy
Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WINGS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.